Competitive Technologies: A Game Changer in Pain Management?

David Greene submits:Competitive Technologies (NYSE Amex: CTT), a company with a groundbreaking chronic pain therapy system utilizing electrical impulses instead of narcotic painkillers, has been a disappointment to shareholders over the past year--until a few days ago.

David Greene submits:Competitive Technologies (CTTC.PK) has had a difficult twelve months, including a change in management. However, the turnaround appears to be at hand. The company's proprietary technology for the treatment of chronic pain, known as Calmare(R) or MC‐5A , has been developing some long-awaited sales momentum with entrepreneurial physicians-- physicians who have evaluated the technology in their own offices, with their own patients.

David Greene submits:Competitive Technologies (CTT) has advanced from $1.50 a mere ten days ago to $3.00 today as the company announced the future publication of a renowned cancer center clinical study on the efficacy of CTT's pain management technology and in reaction to a very positive shareholders' meeting on Monday, April 19.

David Greene submits:Competitive Technologies (AMEX:CTT) has had a difficult time of late--like many other biotechs and medical device companies which had appreciated dramatically prior to presenting at the American Society of Clinical Oncology (ASCO) early last month .

A new study indicating overdose deaths have risen in close parallel with the country’s soaring consumption of prescription narcotics is more evidence the painkillers have become Canada’s most dangerous drugs after tobacco and alcohol — and need concerted, national action, says a leading addiction researcher.

Physical pain is a fairly common occurrence in life, so I suppose everyone walks around figuring it’s a sensation they’re familiar with. But something I learned over this past week is that there was a whole new level of pain far beyond anything I’d previously experienced. In my case, it was caused by a small cyst growing beneath one of my wisdom teeth that was pressing on a nerve in my jaw. And, fortunately, it was easy for an oral surgeon to remove. But it hurt a lot while it lasted, and the experience was terrible.

This article was originally published on Futurity and has been re-printed here under the Creative Commons license.

By Chemistfrog:The fight against cancer is an ongoing and ever-changing battle against a foe that is merciless and persistent. In the past, the treatment arsenal included surgery (resection), radiation, and chemotherapy. More recently, targeted therapies, such as Avastin (Roche Holdings), (RHHBY.PK) have emerged.